Wheezal Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 20-06-2024
- Paid Up Capital ₹ 1.31 M
as on 20-06-2024
- Company Age 43 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.86 Cr
as on 20-06-2024
- Satisfied Charges ₹ 2.95 Cr
as on 20-06-2024
- Revenue -79.71%
(FY 2023)
- Profit -255.05%
(FY 2023)
- Ebitda -140.22%
(FY 2023)
- Net Worth -2.48%
(FY 2023)
- Total Assets -2.57%
(FY 2023)
About Wheezal Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.31 M.
The company currently has active open charges totaling ₹15.86 Cr. The company has closed loans amounting to ₹2.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vibhor Gupta and Sugandh Gupta serve as directors at the Company.
- CIN/LLPIN
U24231UR1981PTC005263
- Company No.
005263
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Apr 1981
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Wheezal Laboratories Private Limited offer?
Wheezal Laboratories Private Limited offers a wide range of products and services, including Homeopathic Medicines & Remedies, Homeopathic Drugs.
Who are the key members and board of directors at Wheezal Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vibhor Gupta  | Director | 13-Dec-2017 | Current |
| Sugandh Gupta | Director | 22-Aug-2012 | Current |
Financial Performance of Wheezal Laboratories.
Wheezal Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 79.71% decrease. The company also saw a substantial fall in profitability, with a 255.05% decrease in profit. The company's net worth dipped by a decrease of 2.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wheezal Laboratories?
Unlock access to Wheezal Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 28 Jul 2011 | ₹15.80 Cr | Open |
Oriental Bank Of Commerce Creation Date: 21 Jan 1995 | ₹0.18 M | Open |
Oriental Bank Of Commerce Creation Date: 21 Mar 1991 | ₹0.40 M | Open |
How Many Employees Work at Wheezal Laboratories?
Unlock and access historical data on people associated with Wheezal Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wheezal Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wheezal Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
